Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands

NCT06607666 · clinicaltrials.gov ↗

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: Lanreotide autogel

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS